1Kaufman HH. Stereotactic aspiration with fibrinolytic and mechanical assistance. In: Kaufman HH, ed. Intracerebral Hematoma. New York, NY: Raven Press, 1992. 182 - 185.
2Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg, 1994, 80:51 - 57.
3Niizuma H, Yonemitsu T, Jokura H, et al. Stereotactic aspiration of thalamic hematoma: overall results of 75 aspirated and 70 nonaspirated cases. Stereotact Funct Neurosurg, 1990, 54 -55:438 -444.
4Teernstra OP, Evers SM, Lodder J, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke, 2003, 34: 968 - 974.
6Findlay JM, Grace MG, Weir BK. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery, 1993, 32: 941 - 947.
7Mayfrank L, Lippitz B, Groth M, et al. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Avta Neurochir (Wien), 1993, 122:32 -38.
8Schwarz S, Schwab S, Steiner HH, et al. Secondary hemorrhage after intraventricular fibrinolysis: a cautionary note: a report of two cases. Neurosurgery, 1998, 42:659 - 662.
9Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized doubleblind, controlled trial. Neurosurgery, 2004, 54:577 - 583.
10Wagner KR, Xi G, Hua Y, et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg, 1999, 90:491 - 498.
2KEMAN WN, VISCOLI CM, LNZUCCHI SE, et al. Prevalence of abnormal glucose tolerance following transient ischemic attack or ischemic stroke [ J ]. Arch Int Med,2005,165 ( 2 ) : 227 - 233.
